A
$ Value
$6K
Shares
2,193
Price
$3
Filed
Sep 16
Insider
Name
Townsend Richard Nolan
Title
Chief Executive Officer
CIK
0001995218
Roles
Director
Officer
Transaction Details
Transaction Date
2025-09-12
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
222,251
Footnotes
The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Lexeo Therapeutics, Inc. 2023 Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d). | Includes 131,092 Restricted Stock Units.
Filing Info
Townsend Richard Nolan's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-06 | LXEO | ▼ | $313K |
| 2025-11-18 | LXEO | ▼ | $10K |
| 2025-10-17 | LXEO | ▼ | $116K |
| 2025-10-17 | LXEO | ▼ | $1K |
| 2025-10-15 | LXEO | A | $0 |
| 2025-09-12 | LXEO | A | $6K |
| 2025-08-18 | LXEO | ▼ | $13K |
| 2025-08-18 | LXEO | ▼ | $5K |
| 2025-05-16 | LXEO | ▼ | $3K |
Other Insiders at LXEO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Townsend Richard Nolan
Chief Executive Officer
|
— | $313K | 2026-04-06 |